Beryl Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 5.65 | 6.29 | 3.21 |
| Operating Expense | 5.08 | 5.30 | 3.18 |
| Net Profit | 0.01 | 0.37 | -0.35 |
| Net Profit Margin | 0.18 | 5.88 | -10.90 |
| Earning Per Share | 0.01 | 0.73 | -0.68 |
| EBIDTA | 0.58 | 1 | 0.03 |
| Effective Tax Rate | 21.05 | 14.14 | -233.33 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 5.65 |
| Operating Expense | 5.08 |
| Net Profit | 0.01 |
| Net Profit Margin | 0.18 |
| Earning Per Share | 0.01 |
| EBIDTA | 0.58 |
| Effective Tax Rate | 21.05 |
Invest in Beryl Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 26.73 | 26.87 | 14.60 |
| Operating Expenses Annual | 24.45 | 24.91 | 14.20 |
| Operating Profit Annual | 2.67 | 2.23 | 0.57 |
| Interest Annual | 0.46 | 0.44 | 0.44 |
| Depreciation | 1.20 | 0.81 | 1.09 |
| Net Profit Annual | 0.77 | 0.77 | -0.66 |
| Tax Annual | 0.24 | 0.22 | -0.29 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 26.73 |
| Operating Expenses Annual | 24.45 |
| Operating Profit Annual | 2.67 |
| Interest Annual | 0.46 |
| Depreciation | 1.20 |
| Net Profit Annual | 0.77 |
| Tax Annual | 0.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.28 | 0.27 | 0.45 |
| Cash Flow from Operations | 0.82 | 2.39 | -0.29 |
| Cash Flow from Investing | -1.08 | -1.18 | 0.54 |
| Cash Flow from Financing | 0.10 | -1.20 | -0.43 |
| Cash Flow at the End | 0.12 | 0.28 | 0.27 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.28 |
| Cash Flow from Operations | 0.82 |
| Cash Flow from Investing | -1.08 |
| Cash Flow from Financing | 0.10 |
| Cash Flow at the End | 0.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 10.33 | 8.45 | 4.11 |
| PBIT Margin (%) | 5.84 | 5.43 | -3.36 |
| PBT Margin (%) | -4.78 | -6.14 | 3.97 |
| Net PROFIT Margin (%) | 2.88 | 2.87 | -4.52 |
| Return On Networth / Equity (%) | 9.07 | 10.03 | -8.67 |
| Return On Networth /Employed (%) | 11.38 | 11.25 | -3.72 |
| Return On Assets (%) | 5.62 | 5.93 | -5.02 |
| Total Debt / Equity (X) | 0.57 | 0.64 | 0.68 |
| Asset Turnover Ratio (%) | 1.95 | 2.07 | 1.11 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 10.33 |
| PBIT Margin (%) | 5.84 |
| PBT Margin (%) | -4.78 |
| Net PROFIT Margin (%) | 2.88 |
| Return On Networth / Equity (%) | 9.07 |
| Return On Networth /Employed (%) | 11.38 |
| Return On Assets (%) | 5.62 |
| Total Debt / Equity (X) | 0.57 |
| Asset Turnover Ratio (%) | 1.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 5.96 | 5.81 | 5.86 |
| Total Current Assets Annual | 10.22 | 10.39 | 10.63 |
| Non Current Assets Annual | 7.27 | 7.12 | 7.20 |
| Total Shareholders Funds Annual | 8.92 | 8.07 | 7.29 |
| Total Assets Annual | 17.49 | 17.51 | 17.82 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 5.96 |
| Total Current Assets Annual | 10.22 |
| Non Current Assets Annual | 7.27 |
| Total Shareholders Funds Annual | 8.92 |
| Total Assets Annual | 17.49 |
No Data Availabe
